Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV90 of Ropivacaine for Infraclavicular Block
NCT03824717Unknown
- Start
- Jan 2019
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of ropivacaine in surgical anesthesia. Primary endpoint: ED90 of 0.5% Ropivacaine at 30 months. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
surgical anesthesia
Beyond the preview
Go deeper on NCT03824717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824717.